About: Shizuoka Cancer Center

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Shizuoka Cancer Center Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

hospital in Japan

Attributes	Values
rdf:type	Item
description	Krankenhaus (de) 병원 (ko) griya sakit (jv) rumah sakik (min) rumoh sakét (ace) hospital de Xapón (ast) hospital di Jepun (ms) rumah sakit di Jepang (id) জাপানের একটি হাসপাতাল (bn) hospital in Japan (en) лікарня в Японії (uk) مستشفى في ناغيزومي، اليابان (ar) bâtiment de Nagaizumi, Shizuoka, Japon (fr) 日本の静岡県駿東郡長泉町にある病院 (ja)
rdfs:label	Shizuoka Cancer Center (en) 静岡県立静岡がんセンター (ja)
skos:prefLabel	Shizuoka Cancer Center (en) 静岡県立静岡がんセンター (ja)
name	Shizuoka Cancer Center (en) 静岡県立静岡がんセンター (ja)
ROR ID	wds:Q11663219-E39959F9-11D7-4B88-B07E-4965A79D4F11
ROR ID	0042ytd14
image	wds:Q11663219-61A16628-AB7D-415F-956D-CD17C63E3959
instance of	wds:Q11663219-332a9ef5-42e8-3005-4d19-d4ff9a174520 wds:Q11663219-d13472db-4117-a69f-3733-282427a1eb2a
image
instance of	hospital medical facility
country	wds:Q11663219-6c2e92a5-419b-cc92-90cf-d8b240902feb
country	Japan
number of hospital beds	wds:Q11663219-50FC22EE-E806-4091-97EC-A0ACBB8EED5D
number of hospital beds	615 (xsd:decimal)
Google Knowledge Graph ID	wds:Q11663219-77C26F08-B511-494E-8027-E786E05DD324
Ringgold ID	wds:Q11663219-6BE7A5C4-083D-4DF8-B878-96DD11FDA404
Google Knowledge Graph ID	http://g.co/kg/g/12345slg
Google Knowledge Graph ID	/g/12345slg
Ringgold ID	38471
inception	wds:Q11663219-0E26CF7D-CA24-4F9D-8866-6575FEC10CF7
inception	2002-09-06 00:00:00Z (xsd:dateTime)
skos:altLabel	静岡がんセンター (ja)
CiNii Research ID	wds:Q11663219-9D8450A7-23FA-406B-8510-471D16EDB44C
OpenStreetMap node ID	wds:Q11663219-D2F2BF87-6FC2-416C-807C-D4AEFA58EE0C
located in the adm...erritorial entity	wds:Q11663219-86883556-42b0-290a-418f-2761e30a09a3
ISNI	wds:Q11663219-B5D7EB1A-A897-489D-BDC4-5D67E53ADD98
VIAF ID	wds:Q11663219-F7A98B79-D565-466F-852E-360252AE417D
NACSIS-CAT author ID	wds:Q11663219-B0338CF7-2928-4A6E-9637-27240B99D936
postal code	wds:Q11663219-1EB85244-3A66-4F77-844F-6F92262F121C
coordinate location	wds:Q11663219-c6abd893-5b75-4575-b631-b5020d74e623
WorldCat Identities ID (superseded)	wds:Q11663219-07CD879A-A7AC-4C80-86AF-ED990BA9772F
official website	wds:Q11663219-8fa77d61-4e4e-5869-9622-ccac52bf28a1
CiNii Research ID	https://cir.nii.ac.jp/crid/1140845216667134592.rdf
VIAF ID	http://viaf.org/viaf/258265610
NACSIS-CAT author ID	https://ci.nii.ac.jp/author/DA1661301X#entity
CiNii Research ID	1140845216667134592
OpenStreetMap node ID	1421002546
located in the adm...erritorial entity	Nagaizumi
ISNI	0000000417749501
VIAF ID	258265610
NACSIS-CAT author ID	DA1661301X
postal code	411-8777
coordinate location	POINT(138.88444444 35.15638889)
WorldCat Identities ID (superseded)	viaf-258265610
official website	https://www.scchr.jp/index.html
GRID ID	wds:Q11663219-779CF8B1-DBC9-44B4-832E-D13A804A664F
GRID ID	grid.415797.9
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q11663219 https://ja.wikipedia.org/wiki/%E9%9D%99%E5%B2%A1%E7%9C%8C%E7%AB%8B%E9%9D%99%E5%B2%A1%E3%81%8C%E3%82%93%E3%82%BB%E3%83%B3%E3%82%BF%E3%83%BC
is research site of	Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Patients With Pretreated Advanced Colorectal Carcinoma DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] Study of DS-8201a for Participants With Advanced Solid Malignant Tumors A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102) Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid Tumors A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer Phase II Study of ABI-007 for Gastric Cancer Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects A Phase I Study of Oral BGJ398 in Asian Patients A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer Phase 2 Study of Brigatinib in Japanese Patients With ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-04/ECHO-305-04) A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130) Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software